Combination chemotherapy with dehydroequol and selected chemotherapeutic agents
CA 2498555 A1 · Owner: Novogen Research Pty Ltd · Inventors: Kelly, Graham Edmund
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to combination therapies involving anticancer chemotherapeutic agents and isoflavones or analogues thereof. The invention further relates to compounds, compositions methods and therapeutic uses , involving containing, comprising, including and/or for preparing platinumisoflavonoid complexes suitable for use in the combination therapies of the invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 2, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 2, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 2, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.